Skip to main navigation
Close
Menu
Main navigation
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Resources
All Resources
Drug Shortages White Paper
2023 Savings Report
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action
Breadcrumb
Association for Accessible Medicines
Resources
Blog
Blog
Share
Blog
Oct 26, 2017
| Erica Klinger
The Medicaid Generics Penalty: A Primer (Part 1)
Blog
Oct 20, 2017
| Allen Goldberg
AAM Tells Senate: Generics Are Solution to High Drug Prices
Blog
Oct 16, 2017
| Rachel Schwartz
The Generic Drug Supply Chain
Blog
Oct 10, 2017
| Erica Klinger
Health Care Orgs Urge Congress to Take Close Look at Allergan Deal
Blog
Sep 22, 2017
| Erica Klinger
What’s the Difference Between Generics and Brand-Name Drugs?
Blog
Sep 7, 2017
| Michael Brzica
Support the CREATES Act and Help Patients Win
Blog
Sep 6, 2017
| Erica Klinger
Take Action on SB 17 to Protect Patient Access and Savings for Californians
Blog
Aug 23, 2017
| Christine Simmon
Five Reasons Why It’s Time to Lead on Biosimilars
Blog
Aug 9, 2017
| Erica Klinger
NYT: Generic Drug Prices Are Falling, but Are Consumers Benefiting?
Blog
Jul 28, 2017
| Erica Klinger
How Much Did Generics Save You and Your State in 2016?
Blog
Jul 18, 2017
| Erica Klinger
Using Safety Programs to Protect Profits, Not Patients
Blog
Jun 8, 2017
| Erica Klinger
2017 Generic Drug Access and Savings in the U.S. Report
Load More
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Access! 2024
GRx+Biosims 2023
Resources
All Resources
Drug Shortages White Paper
2023 Savings Report
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action